Imodium Instants

Loperamide, the active ingredient in Imodium Instants, is a peripheral opioid receptor agonist presented as an oral soluble tablet for oral use. It reduces intestinal motility and increases water absorption, providing symptomatic relief for acute nonspecific diarrhea, chronic diarrhea and irritable bowel syndrome with diarrhea in adult patients.

GNH USA supplies Imodium Instants as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled sourcing and regulatory compliance for reliable logistics through global distribution.

Loperamide acts on the gastrointestinal motility pathway to control diarrheal conditions.

Acute nonspecific diarrhea: decreases stool frequency and urgency by slowing intestinal transit and enhancing fluid absorption. Chronic diarrhea: offers symptomatic control through reduced motility, helping to normalize stool form and frequency over longer periods. Irritable bowel syndrome with diarrhea (IBS‑D): mitigates frequent loose stools and abdominal discomfort by modulating gut motility and water balance.

Loperamide may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Abdominal cramps: mild to moderate discomfort in the abdomen. - Constipation: reduced bowel movements or hard stools. - Nausea: feeling of queasiness. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Severe constipation or intestinal obstruction: risk of blockage requiring medical attention. - Toxic megacolon: rare but life‑threatening dilation of the colon. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

When using Loperamide, certain precautions should be observed to ensure safe and effective therapy. - Assess underlying cause: confirm that diarrhea is not due to infection before use. - Avoid in bacterial enterocolitis: risk of worsening infection. - Limit duration: discontinue if symptoms persist beyond 48 hours without improvement. - Use with caution in hepatic impairment: drug metabolism may be reduced. - Avoid concomitant use with strong CYP3A4 inhibitors: may increase systemic exposure. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Loperamide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise plasma levels and increase risk of serious cardiac effects. - P-glycoprotein inhibitors (e.g., quinidine, verapamil): can enhance central exposure and precipitate toxicity.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: additive constipating effect may lead to severe constipation. - Opioid analgesics: combined opioid effect may increase sedation or respiratory depression. - Rifampin: enzyme inducer may reduce loperamide effectiveness.